{"entity":{"type":"insider","cik":"0001780854","url":"/insider/0001780854","json_url":"/insider/0001780854.json","name":"BENZENO SHARON","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":50,"n_filings":33,"first":"2020-05-21","last":"2026-06-30","span_basis":"filed_date"},"name_variants":[{"name":"BENZENO SHARON","source":"filing","n_filings":33,"first_seen":"2020-05-21","last_seen":"2026-06-30"}],"transactions":[{"id":5876432,"accession":"0001780854-26-000008","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001780854-26-000008","line_url":"/filing/0001780854-26-000008#line-7","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780854","owner_name":"BENZENO SHARON","owner_display_name":"BENZENO SHARON","owner_url":"/insider/0001780854","role":"Officer (Chief Commercial Ofc Imm Med)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Ofc Imm Med)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Ofc Imm Med","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":154768.0,"shares_display":"154,768","price_per_share":21.14,"price_display":"21.14","price_state":"stated","total_value":3271795.52,"total_display":"3,271,795.52","total_whole":"3,271,796","shares_owned_after":221278.0,"shares_owned_after_display":"221,278","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-29","filed_date":"2026-06-30","scope":"insider"},{"id":5876423,"accession":"0001780854-26-000008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001780854-26-000008","line_url":"/filing/0001780854-26-000008#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780854","owner_name":"BENZENO SHARON","owner_display_name":"BENZENO SHARON","owner_url":"/insider/0001780854","role":"Officer (Chief Commercial Ofc Imm Med)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Ofc Imm Med)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Ofc Imm Med","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11034.0,"shares_display":"11,034","price_per_share":21.0,"price_display":"21.00","price_state":"stated","total_value":231714.0,"total_display":"231,714.00","total_whole":"231,714","shares_owned_after":272751.0,"shares_owned_after_display":"272,751","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-26","filed_date":"2026-06-30","scope":"insider"},{"id":5758819,"accession":"0001780854-26-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001780854-26-000004","line_url":"/filing/0001780854-26-000004#line-1","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780854","owner_name":"BENZENO SHARON","owner_display_name":"BENZENO SHARON","owner_url":"/insider/0001780854","role":"Officer (Chief Commercial Ofc Imm Med)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Ofc Imm Med)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Ofc Imm Med","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":63103.0,"shares_display":"63,103","price_per_share":13.17,"price_display":"13.17","price_state":"stated","total_value":831066.51,"total_display":"831,066.51","total_whole":"831,067","shares_owned_after":272751.0,"shares_owned_after_display":"272,751","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-11","filed_date":"2026-03-13","scope":"insider"},{"id":4560579,"accession":"0001780854-25-000003","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001780854-25-000003","line_url":"/filing/0001780854-25-000003#line-4","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780854","owner_name":"BENZENO SHARON","owner_display_name":"BENZENO SHARON","owner_url":"/insider/0001780854","role":"Officer (Chief Commercial Ofc Imm Med)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Ofc Imm Med)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Ofc Imm Med","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12604.0,"shares_display":"12,604","price_per_share":16.85,"price_display":"16.85","price_state":"stated","total_value":212377.4,"total_display":"212,377.40","total_whole":"212,377","shares_owned_after":296791.0,"shares_owned_after_display":"296,791","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-04","filed_date":"2025-12-08","scope":"insider"},{"id":4186303,"accession":"0001780854-25-000002","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001780854-25-000002","line_url":"/filing/0001780854-25-000002#line-10","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780854","owner_name":"BENZENO SHARON","owner_display_name":"BENZENO SHARON","owner_url":"/insider/0001780854","role":"Officer (Chief Commercial Ofc Imm Med)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Ofc Imm Med)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Ofc Imm Med","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":308477.0,"shares_display":"308,477","price_per_share":16.91,"price_display":"16.91","price_state":"stated","total_value":5216346.07,"total_display":"5,216,346.07","total_whole":"5,216,346","shares_owned_after":296791.0,"shares_owned_after_display":"296,791","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-21","filed_date":"2025-11-24","scope":"insider"},{"id":4186277,"accession":"0001780854-25-000002","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001780854-25-000002","line_url":"/filing/0001780854-25-000002#line-3","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780854","owner_name":"BENZENO SHARON","owner_display_name":"BENZENO SHARON","owner_url":"/insider/0001780854","role":"Officer (Chief Commercial Ofc Imm Med)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Ofc Imm Med)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Ofc Imm Med","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":297925.0,"shares_display":"297,925","price_per_share":16.54,"price_display":"16.54","price_state":"stated","total_value":4927679.5,"total_display":"4,927,679.50","total_whole":"4,927,680","shares_owned_after":296791.0,"shares_owned_after_display":"296,791","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-20","filed_date":"2025-11-24","scope":"insider"},{"id":4664229,"accession":"0001062993-25-004815","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001062993-25-004815","line_url":"/filing/0001062993-25-004815","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780854","owner_name":"BENZENO SHARON","owner_display_name":"BENZENO SHARON","owner_url":"/insider/0001780854","role":"Officer (Chief Commercial Ofc Imm Med)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Ofc Imm Med)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Ofc Imm Med","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":44665.0,"shares_display":"44,665","price_per_share":6.980686219635061,"price_display":"6.98","price_state":"stated","total_value":311792.35,"total_display":"311,792.35","total_whole":"311,792","shares_owned_after":395788.0,"shares_owned_after_display":"395,788","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-05","filed_date":"2025-03-06","scope":"insider","n_lines":2},{"id":2041361,"accession":"0001062993-24-005762","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001062993-24-005762","line_url":"/filing/0001062993-24-005762","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780854","owner_name":"BENZENO SHARON","owner_display_name":"BENZENO SHARON","owner_url":"/insider/0001780854","role":"Officer (Chief Commercial Ofc Imm Med)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Ofc Imm Med)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Ofc Imm Med","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29390.0,"shares_display":"29,390","price_per_share":3.436343654304185,"price_display":"3.44","price_state":"stated","total_value":100994.14,"total_display":"100,994.14","total_whole":"100,994","shares_owned_after":327415.0,"shares_owned_after_display":"327,415","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-05","filed_date":"2024-03-06","scope":"insider","n_lines":2},{"id":7889853,"accession":"0001062993-23-006325","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-23-006325","line_url":"/filing/0001062993-23-006325#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780854","owner_name":"BENZENO SHARON","owner_display_name":"BENZENO SHARON","owner_url":"/insider/0001780854","role":"Officer (Chief Commercial Ofc Imm Med)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Ofc Imm Med)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Ofc Imm Med","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11749.0,"shares_display":"11,749","price_per_share":8.57,"price_display":"8.57","price_state":"stated","total_value":100688.93,"total_display":"100,688.93","total_whole":"100,689","shares_owned_after":223826.0,"shares_owned_after_display":"223,826","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-06","filed_date":"2023-03-08","scope":"insider"},{"id":6345476,"accession":"0001209191-22-017398","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-017398","line_url":"/filing/0001209191-22-017398#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780854","owner_name":"BENZENO SHARON","owner_display_name":"BENZENO SHARON","owner_url":"/insider/0001780854","role":"Officer (Chief Business Development Off)","role_mark":"O","role_mark_label":"Officer (Chief Business Development Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Development Off","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2670.0,"shares_display":"2,670","price_per_share":12.01,"price_display":"12.01","price_state":"stated","total_value":32066.7,"total_display":"32,066.70","total_whole":"32,067","shares_owned_after":102596.0,"shares_owned_after_display":"102,596","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-07","filed_date":"2022-03-08","scope":"insider"},{"id":4619239,"accession":"0001209191-21-021548","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-021548","line_url":"/filing/0001209191-21-021548","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780854","owner_name":"BENZENO SHARON","owner_display_name":"BENZENO SHARON","owner_url":"/insider/0001780854","role":"Officer (Chief Business Development Off)","role_mark":"O","role_mark_label":"Officer (Chief Business Development Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Development Off","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1354.0,"shares_display":"1,354","price_per_share":41.691802067946824,"price_display":"41.69","price_state":"stated","total_value":56450.7,"total_display":"56,450.70","total_whole":"56,451","shares_owned_after":22894.0,"shares_owned_after_display":"22,894","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-15","filed_date":"2021-03-17","scope":"insider","n_lines":2},{"id":4330554,"accession":"0001209191-21-017305","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-017305","line_url":"/filing/0001209191-21-017305","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780854","owner_name":"BENZENO SHARON","owner_display_name":"BENZENO SHARON","owner_url":"/insider/0001780854","role":"Officer (Chief Business Development Off)","role_mark":"O","role_mark_label":"Officer (Chief Business Development Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Development Off","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6771.0,"shares_display":"6,771","price_per_share":57.619712007089056,"price_display":"57.62","price_state":"stated","total_value":390143.07,"total_display":"390,143.07","total_whole":"390,143","shares_owned_after":561.0,"shares_owned_after_display":"561","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-03","scope":"insider","n_lines":2},{"id":5374643,"accession":"0001209191-21-017308","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-017308","line_url":"/filing/0001209191-21-017308#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780854","owner_name":"BENZENO SHARON","owner_display_name":"BENZENO SHARON","owner_url":"/insider/0001780854","role":"Officer (Chief Business Development Off)","role_mark":"O","role_mark_label":"Officer (Chief Business Development Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Development Off","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":416.0,"shares_display":"416","price_per_share":61.2,"price_display":"61.20","price_state":"stated","total_value":25459.2,"total_display":"25,459.20","total_whole":"25,459","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-19","filed_date":"2021-03-03","scope":"insider"},{"id":4659378,"accession":"0001209191-21-011553","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-011553","line_url":"/filing/0001209191-21-011553","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780854","owner_name":"BENZENO SHARON","owner_display_name":"BENZENO SHARON","owner_url":"/insider/0001780854","role":"Officer (Chief Business Development Off)","role_mark":"O","role_mark_label":"Officer (Chief Business Development Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Development Off","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16250.0,"shares_display":"16,250","price_per_share":64.63885292307693,"price_display":"64.64","price_state":"stated","total_value":1050381.36,"total_display":"1,050,381.36","total_whole":"1,050,381","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-16","filed_date":"2021-02-17","scope":"insider","n_lines":3},{"id":4415372,"accession":"0001209191-21-007547","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-007547","line_url":"/filing/0001209191-21-007547","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780854","owner_name":"BENZENO SHARON","owner_display_name":"BENZENO SHARON","owner_url":"/insider/0001780854","role":"Officer (Chief Business Development Off)","role_mark":"O","role_mark_label":"Officer (Chief Business Development Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Development Off","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6770.0,"shares_display":"6,770","price_per_share":55.645450516986706,"price_display":"55.65","price_state":"stated","total_value":376719.7,"total_display":"376,719.70","total_whole":"376,720","shares_owned_after":300.0,"shares_owned_after_display":"300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-01","filed_date":"2021-02-03","scope":"insider","n_lines":2},{"id":5090941,"accession":"0001209191-21-004523","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-004523","line_url":"/filing/0001209191-21-004523#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780854","owner_name":"BENZENO SHARON","owner_display_name":"BENZENO SHARON","owner_url":"/insider/0001780854","role":"Officer (Chief Business Development Off)","role_mark":"O","role_mark_label":"Officer (Chief Business Development Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Development Off","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":417.0,"shares_display":"417","price_per_share":69.0,"price_display":"69.00","price_state":"stated","total_value":28773.0,"total_display":"28,773.00","total_whole":"28,773","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-19","filed_date":"2021-01-20","scope":"insider"},{"id":4820716,"accession":"0001209191-21-002378","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-21-002378","line_url":"/filing/0001209191-21-002378","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780854","owner_name":"BENZENO SHARON","owner_display_name":"BENZENO SHARON","owner_url":"/insider/0001780854","role":"Officer (Chief Business Development Off)","role_mark":"O","role_mark_label":"Officer (Chief Business Development Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Development Off","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6771.0,"shares_display":"6,771","price_per_share":57.38927041795894,"price_display":"57.39","price_state":"stated","total_value":388582.75,"total_display":"388,582.75","total_whole":"388,583","shares_owned_after":762.0,"shares_owned_after_display":"762","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-04","filed_date":"2021-01-06","scope":"insider","n_lines":4},{"id":2120865,"accession":"0001209191-20-065101","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-065101","line_url":"/filing/0001209191-20-065101#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780854","owner_name":"BENZENO SHARON","owner_display_name":"BENZENO SHARON","owner_url":"/insider/0001780854","role":"Officer (Chief Business Development Off)","role_mark":"O","role_mark_label":"Officer (Chief Business Development Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Development Off","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":417.0,"shares_display":"417","price_per_share":59.14,"price_display":"59.14","price_state":"stated","total_value":24661.38,"total_display":"24,661.38","total_whole":"24,661","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-21","filed_date":"2020-12-23","scope":"insider"},{"id":2445996,"accession":"0001209191-20-061326","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-20-061326","line_url":"/filing/0001209191-20-061326","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780854","owner_name":"BENZENO SHARON","owner_display_name":"BENZENO SHARON","owner_url":"/insider/0001780854","role":"Officer (Chief Business Development Off)","role_mark":"O","role_mark_label":"Officer (Chief Business Development Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Development Off","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6770.0,"shares_display":"6,770","price_per_share":48.87095864106352,"price_display":"48.87","price_state":"stated","total_value":330856.39,"total_display":"330,856.39","total_whole":"330,856","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-01","filed_date":"2020-12-02","scope":"insider","n_lines":2},{"id":2146304,"accession":"0001209191-20-059855","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-059855","line_url":"/filing/0001209191-20-059855#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780854","owner_name":"BENZENO SHARON","owner_display_name":"BENZENO SHARON","owner_url":"/insider/0001780854","role":"Officer (Chief Business Development Off)","role_mark":"O","role_mark_label":"Officer (Chief Business Development Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Development Off","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":416.0,"shares_display":"416","price_per_share":48.86,"price_display":"48.86","price_state":"stated","total_value":20325.76,"total_display":"20,325.76","total_whole":"20,326","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-19","filed_date":"2020-11-23","scope":"insider"},{"id":2838993,"accession":"0001209191-20-057007","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-20-057007","line_url":"/filing/0001209191-20-057007","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780854","owner_name":"BENZENO SHARON","owner_display_name":"BENZENO SHARON","owner_url":"/insider/0001780854","role":"Officer (Chief Business Development Off)","role_mark":"O","role_mark_label":"Officer (Chief Business Development Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Development Off","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6772.0,"shares_display":"6,772","price_per_share":45.5762581216775,"price_display":"45.58","price_state":"stated","total_value":308642.42,"total_display":"308,642.42","total_whole":"308,642","shares_owned_after":1074.0,"shares_owned_after_display":"1,074","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-02","filed_date":"2020-11-04","scope":"insider","n_lines":2},{"id":3131070,"accession":"0001209191-20-055402","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-055402","line_url":"/filing/0001209191-20-055402#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780854","owner_name":"BENZENO SHARON","owner_display_name":"BENZENO SHARON","owner_url":"/insider/0001780854","role":"Officer (Chief Business Development Off)","role_mark":"O","role_mark_label":"Officer (Chief Business Development Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Development Off","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":417.0,"shares_display":"417","price_per_share":51.25,"price_display":"51.25","price_state":"stated","total_value":21371.25,"total_display":"21,371.25","total_whole":"21,371","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-19","filed_date":"2020-10-20","scope":"insider"},{"id":3260627,"accession":"0001209191-20-053371","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-20-053371","line_url":"/filing/0001209191-20-053371","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780854","owner_name":"BENZENO SHARON","owner_display_name":"BENZENO SHARON","owner_url":"/insider/0001780854","role":"Officer (Chief Business Development Off)","role_mark":"O","role_mark_label":"Officer (Chief Business Development Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Development Off","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6771.0,"shares_display":"6,771","price_per_share":48.565508787476,"price_display":"48.57","price_state":"stated","total_value":328837.06,"total_display":"328,837.06","total_whole":"328,837","shares_owned_after":893.0,"shares_owned_after_display":"893","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-01","filed_date":"2020-10-02","scope":"insider","n_lines":2},{"id":2472529,"accession":"0001209191-20-051733","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-051733","line_url":"/filing/0001209191-20-051733#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780854","owner_name":"BENZENO SHARON","owner_display_name":"BENZENO SHARON","owner_url":"/insider/0001780854","role":"Officer (Chief Business Development Off)","role_mark":"O","role_mark_label":"Officer (Chief Business Development Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Development Off","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":417.0,"shares_display":"417","price_per_share":45.51,"price_display":"45.51","price_state":"stated","total_value":18977.67,"total_display":"18,977.67","total_whole":"18,978","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-21","filed_date":"2020-09-23","scope":"insider"},{"id":3199649,"accession":"0001209191-20-049271","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-20-049271","line_url":"/filing/0001209191-20-049271","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780854","owner_name":"BENZENO SHARON","owner_display_name":"BENZENO SHARON","owner_url":"/insider/0001780854","role":"Officer (Chief Business Development Off)","role_mark":"O","role_mark_label":"Officer (Chief Business Development Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Development Off","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6771.0,"shares_display":"6,771","price_per_share":41.30082410279132,"price_display":"41.30","price_state":"stated","total_value":279647.88,"total_display":"279,647.88","total_whole":"279,648","shares_owned_after":300.0,"shares_owned_after_display":"300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-01","filed_date":"2020-09-02","scope":"insider","n_lines":2},{"id":3167524,"accession":"0001209191-20-047642","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-047642","line_url":"/filing/0001209191-20-047642#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780854","owner_name":"BENZENO SHARON","owner_display_name":"BENZENO SHARON","owner_url":"/insider/0001780854","role":"Officer (Chief Business Development Off)","role_mark":"O","role_mark_label":"Officer (Chief Business Development Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Development Off","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":416.0,"shares_display":"416","price_per_share":41.57,"price_display":"41.57","price_state":"stated","total_value":17293.12,"total_display":"17,293.12","total_whole":"17,293","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-19","filed_date":"2020-08-19","scope":"insider"},{"id":2343319,"accession":"0001209191-20-045397","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-20-045397","line_url":"/filing/0001209191-20-045397#line-5","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780854","owner_name":"BENZENO SHARON","owner_display_name":"BENZENO SHARON","owner_url":"/insider/0001780854","role":"Officer (Chief Business Development Off)","role_mark":"O","role_mark_label":"Officer (Chief Business Development Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Development Off","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7187.0,"shares_display":"7,187","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":287480.0,"total_display":"287,480.00","total_whole":"287,480","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-04","filed_date":"2020-08-05","scope":"insider"},{"id":2370829,"accession":"0001209191-20-043123","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-043123","line_url":"/filing/0001209191-20-043123#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780854","owner_name":"BENZENO SHARON","owner_display_name":"BENZENO SHARON","owner_url":"/insider/0001780854","role":"Officer (Chief Business Development Off)","role_mark":"O","role_mark_label":"Officer (Chief Business Development Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Development Off","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":417.0,"shares_display":"417","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":16680.0,"total_display":"16,680.00","total_whole":"16,680","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-20","filed_date":"2020-07-21","scope":"insider"},{"id":2586271,"accession":"0001209191-20-040677","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-20-040677","line_url":"/filing/0001209191-20-040677","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780854","owner_name":"BENZENO SHARON","owner_display_name":"BENZENO SHARON","owner_url":"/insider/0001780854","role":"Officer (Chief Business Development Off)","role_mark":"O","role_mark_label":"Officer (Chief Business Development Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Development Off","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6771.0,"shares_display":"6,771","price_per_share":47.34013735046522,"price_display":"47.34","price_state":"stated","total_value":320540.07,"total_display":"320,540.07","total_whole":"320,540","shares_owned_after":1200.0,"shares_owned_after_display":"1,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-01","filed_date":"2020-07-02","scope":"insider","n_lines":2},{"id":2510918,"accession":"0001209191-20-039543","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-039543","line_url":"/filing/0001209191-20-039543#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780854","owner_name":"BENZENO SHARON","owner_display_name":"BENZENO SHARON","owner_url":"/insider/0001780854","role":"Officer (Chief Business Development Off)","role_mark":"O","role_mark_label":"Officer (Chief Business Development Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Development Off","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":417.0,"shares_display":"417","price_per_share":47.42,"price_display":"47.42","price_state":"stated","total_value":19774.14,"total_display":"19,774.14","total_whole":"19,774","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-26","filed_date":"2020-06-30","scope":"insider"},{"id":2111212,"accession":"0001209191-20-039564","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-039564","line_url":"/filing/0001209191-20-039564#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780854","owner_name":"BENZENO SHARON","owner_display_name":"BENZENO SHARON","owner_url":"/insider/0001780854","role":"Officer (Chief Business Development Off)","role_mark":"O","role_mark_label":"Officer (Chief Business Development Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Development Off","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":417.0,"shares_display":"417","price_per_share":47.42,"price_display":"47.42","price_state":"stated","total_value":19774.14,"total_display":"19,774.14","total_whole":"19,774","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-26","filed_date":"2020-07-01","scope":"insider"},{"id":3115270,"accession":"0001209191-20-038658","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-038658","line_url":"/filing/0001209191-20-038658#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780854","owner_name":"BENZENO SHARON","owner_display_name":"BENZENO SHARON","owner_url":"/insider/0001780854","role":"Officer (Chief Business Development Off)","role_mark":"O","role_mark_label":"Officer (Chief Business Development Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Development Off","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":417.0,"shares_display":"417","price_per_share":45.0,"price_display":"45.00","price_state":"stated","total_value":18765.0,"total_display":"18,765.00","total_whole":"18,765","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-19","filed_date":"2020-06-23","scope":"insider"},{"id":2370114,"accession":"0001209191-20-034877","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-034877","line_url":"/filing/0001209191-20-034877#line-4","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780854","owner_name":"BENZENO SHARON","owner_display_name":"BENZENO SHARON","owner_url":"/insider/0001780854","role":"Officer (Chief Business Development Off)","role_mark":"O","role_mark_label":"Officer (Chief Business Development Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Development Off","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6770.0,"shares_display":"6,770","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":270800.0,"total_display":"270,800.00","total_whole":"270,800","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-03","filed_date":"2020-06-05","scope":"insider"},{"id":2682838,"accession":"0001209191-20-032803","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-032803","line_url":"/filing/0001209191-20-032803#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780854","owner_name":"BENZENO SHARON","owner_display_name":"BENZENO SHARON","owner_url":"/insider/0001780854","role":"Officer (Chief Business Development Off)","role_mark":"O","role_mark_label":"Officer (Chief Business Development Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Development Off","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":416.0,"shares_display":"416","price_per_share":42.0,"price_display":"42.00","price_state":"stated","total_value":17472.0,"total_display":"17,472.00","total_whole":"17,472","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-26","filed_date":"2020-05-28","scope":"insider"},{"id":3257117,"accession":"0001209191-20-031541","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-20-031541","line_url":"/filing/0001209191-20-031541#line-7","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780854","owner_name":"BENZENO SHARON","owner_display_name":"BENZENO SHARON","owner_url":"/insider/0001780854","role":"Officer (Chief Business Development Off)","role_mark":"O","role_mark_label":"Officer (Chief Business Development Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Development Off","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":246770.0,"shares_display":"246,770","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":9870800.0,"total_display":"9,870,800.00","total_whole":"9,870,800","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-19","filed_date":"2020-05-21","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":50,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":50,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":50},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001478320","name":"Adaptive Biotechnologies Corp","url":"/issuer/0001478320","role":"Officer (Chief Commercial Ofc Imm Med)","n_filings":33,"first_seen":"2020-05-21","last_seen":"2026-06-30"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001780854","retrieved_at":"2026-08-23T15:08:40+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}